Classification of Odontogenic Sinusitis: A Clinical-Based Phenotyping System to Guide Multidisciplinary Surgical Management. [PDF]
Sabatino L +8 more
europepmc +1 more source
Abstract Objectives Adalimumab biosimilars are as safe and effective compared to the originator. Adult patients with inflammatory bowel disease (IBD) who switched to a biosimilar have comparable outcomes, but pediatric data are limited. This study evaluates clinical outcomes of children and young adults with IBD following a nonmedical, insurance‐driven
Daniel Himelstein +5 more
wiley +1 more source
Management of concomitant cholecystoduodenal and cholecystocolonic fistulas with sigmoid colonic gallstone: a case report. [PDF]
Akingboye A +4 more
europepmc +1 more source
Diffuse gallbladder epithelial proliferation after teduglutide exposure: A case report
Abstract Teduglutide, a glucagon‐like peptide 2 analog that increases mucosal proliferation in the gastrointestinal tract, was approved by the U.S. Food and Drug Administration for use in children with intestinal failure in 2019 after trials of 12‐ and 24‐week duration.
Christopher P. Duggan +4 more
wiley +1 more source
Parenteral Nutrition as a Strategic Therapeutic Option for Onco-Geriatric Rehabilitation After Total Gastrectomy and Anastomotic Stenosis Complicated by an Aorto-Esophageal Fistula: A Case Report. [PDF]
Belaid HE, De Carvalho JG, Gagliano M.
europepmc +1 more source
Abstract Inflammatory bowel disease (IBD) is a chronic inflammatory disorder often presenting with extra‐intestinal manifestations (EIMs) involving the skin, joints and eyes. However, pulmonary manifestation, such as interstitial lung disease (ILD), is a rare complication, particularly in the pediatric population. We report a case of a 10‐year‐old boy,
Harshit Vachher +5 more
wiley +1 more source
Small Bowel-Vesical Fistula with Chronic Kidney Disease Relating to Administration of Sodium Polystyrene Sulfonate: A Case Report. [PDF]
Kawahara H +6 more
europepmc +1 more source
Capsule Summary Xeroderma pigmentosum (XP) is associated with a high risk of multiple and aggressive cutaneous squamous cell carcinomas (CSCCs). The immune checkpoint inhibitor cemiplimab has been approved in advanced, unresectable, and/or metastatic CSCCs.
Sudip Parajuli +5 more
wiley +1 more source
Early Oral Gastrografin Followed by Immediate CT for Precise Leak Localization and Surgical Planning After Total Laryngectomy. [PDF]
Jeong SJ +5 more
europepmc +1 more source
Microvascular Free Flap Transfer for the Closure of Recalcitrant Digestive Fistulas: A Systematic Review of Surgical Success, Definitive Closure, and Clinical Outcomes. [PDF]
Vega Morales AQ +8 more
europepmc +1 more source

